Search
Bone Biologics Corp
BBLGAdd to Watchlist
1.420USD
+0.020+1.43%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
2.55MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+1.43%
5 Days
+1.43%
1 Month
+13.60%
6 Months
-7.79%
Year to Date
-2.07%
1 Year
-59.31%
Key Figures
1.340Open
1.420High
19.64KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.09%Turnover Ratio
1.400Prev. Close
1.340Low
20.06KTurnover
LossP/E Static
0.55P/B
0.00%Div Yield TTM
-70.21%ROA
6.75052wk High
1.21Volume Ratio
-7.32MNet Profit
1.80MShares
-1.1558EPS TTM
0.93Beta
-75.40%ROE
1.05052wk Low
5.71%Amplitude
--Gross Margin
2.55MMarket Cap
2.80Reward/Risk
4.28%Risk Rate
TradingKey Stock Score of Bone Biologics Corp
Currency: USD Updated: 2026-07-02Key Insights
Bone Biologics Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 222 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 22.20.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bone Biologics Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Bone Biologics Corp Highlights
StrengthsRisks
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Undervalued
The company’s latest PE is -1.23, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 58.41K shares, increasing 27.37% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
22.200
Target Price
+1485.71%
Upside Space
Bone Biologics Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Bone Biologics Corp Info
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
Ticker SymbolBBLG
CompanyBone Biologics Corp
CEOFrelick (Jeffrey)
Websitehttps://www.bonebiologics.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Bone Biologics Corp (BBLG)?
The current price of Bone Biologics Corp (BBLG) is 1.42.
What is the symbol of Bone Biologics Corp?
The ticker symbol of Bone Biologics Corp is BBLG.
What is the 52-week high of Bone Biologics Corp?
The 52-week high of Bone Biologics Corp is 6.75.
What is the 52-week low of Bone Biologics Corp?
The 52-week low of Bone Biologics Corp is 1.05.
What is the market capitalization of Bone Biologics Corp?
The market capitalization of Bone Biologics Corp is 2.55M.
What is the Earnings Per Share (EPS TTM) of Bone Biologics Corp (BBLG)?
The Earnings Per Share (EPS TTM) of Bone Biologics Corp (BBLG) is -2.65.